Cloxacillin benzathine

This classification denotes a penicillin antibiotic with the molecular formula 2C19H18ClN3O5S.C16H20N2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier AC79L7PV2G, chemically known as 4-thia-1-azabicyclo(3.2.0)heptane-2-carboxylic acid, 6-(((3-(2-chlorophenyl)-5-methyl-4-isoxazolyl)carbonyl)amino)-3,3-dimethyl-7-oxo-, (2s-(2.alpha.,5.alpha.,6.beta.))-, compd. with n,n'-bis(phenylmethyl)-1,2-ethanediamine (2:1), but more generally known as cloxacillin benzathine, which bears US NIH Compound Identifier 64706. European Medicines Agency schedules cloxacillin benzathine or its base in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06780MIG. Most nations, for tariff purposes, schedule cloxacillin benzathine under HS 29411090. Cloxacillin benzathine bears US NLM identifiers UMLS ID C0053154 and NCI Concept Code C76854. SMILES: CC1C(C(NO1)C2CCCCC2CL)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O.CC1C(C(NO1)C2CCCCC2CL)C(=O)N[C@H]3[C@@H]4N(C3=O)[C@H](C(S4)(C)C)C(=O)O.C1CCC(CC1)CNCCNCC2CCCCC2.